FDA-Drug2020-12-02Class III
DOXOrubicin Hydrochloride Injection, USP, 10 mg / 5 mL (2 mg / mL), 5 mL fill in a 6 mL vial, Single Dose Vial, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047. NDC: 63323-883-05
Fresenius Kabi USA, LLC
Hazard
Cross Contamination with Other Products: trace amounts of octreotide found during testing
Sold states
Nationwide USA and Puerto Rico
Affected count
16,986 vials
Manufactured in
3 Corporate Dr, N/A, Lake Zurich, IL, United States
Products
DOXOrubicin Hydrochloride Injection, USP, 10 mg / 5 mL (2 mg / mL), 5 mL fill in a 6 mL vial, Single Dose Vial, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047. NDC: 63323-883-05
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0105-2021Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief